Please login to the form below

Not currently logged in
Email:
Password:

Mosquirix

This page shows the latest Mosquirix news and features for those working in and with pharma, biotech and healthcare.

Dosing of GSK's malaria vaccine due to start in 2018

Dosing of GSK's malaria vaccine due to start in 2018

GSK's vaccine – also known as Mosquirix – is considered to have limited efficacy, but the sheer scale of the public health problem posed by malaria in some areas of the world

Latest news

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    GSK's malarial vaccine, Mosquirix which also contains Agenus’QS-21 Stimulon, was approved for use by the EMA in 2015.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics